Genus Plc (GNS.L), a biotechnology firm focused on animal genetics, said on Wednesday that it has recorded a strong performance for the first half and expects its earnings ahead of expectations.
For the six-month period to December 31, 2024, the company projects to post an adjusted profit before tax of at least 35 million pounds in actual currency, which is ahead of expectations.
Looking ahead, for the full year, the Board now expects annual adjusted profit before tax to be at the top-end of the range of market expectations in actual currency of 63 million pounds to 67.4 million pounds with an average of 64.1 million pounds.
Earlier, the company was expecting its annual adjusted profit before tax to be in-line with market expectations.
Genus is scheduled to release its first-half interim results on February 27.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.